Covid 19 Research using Clinical Trials (Home Page)
Report for D035583: Rare Diseases NIH
(Synonyms: Rare Diseases)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (0)
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Clinical Trials
1 COVID-19 and Rare Skin Diseases. European Observational Study (Data Research) During an Epidemic
This is a European observational cohort study (data research) involving multiple centres to look at the potential impact of COVID infection on patients with rare skin diseases examining factors such as comorbidity, protection factors, and clinical and/or therapeutic factors. The data collected may provide additional information on the situation of patients and, on a wider basis, provide useful data applicable to the general population.
NCT04451902 Rare Diseases MeSH:Skin Diseases Rare Diseases
HPO:Abnormality of the skin
Primary Outcomes
Description: Frequency of hospitalisations related to suspected and confirmed cases of Covid-19 infection and consequences
Measure: Analysis of the impact of COVID-19 infection on rare skin diseases: complications Time: Baseline
Description: Frequency of hospitalisations related to suspected and confirmed cases of Covid-19 infection and analysis of associated factors: age, gender, pathology, comorbidities, medications
Measure: Analysis of the impact of COVID-19 infection on rare skin diseases: potential comorbidity factors Time: Baseline
Description: Frequency of confirmed and suspected unconfirmed Covid-19 infections; description of clinical signs and signs of an impact on the chronic disease; description of possible therapeutic changes due to the Covid-19 infections
Measure: Analysis of the impact of COVID-19 infection on rare skin diseases: impact on the management of chronic conditions (change in treatment) Time: Baseline
HPO Nodes
Primary Outcomes
Description: Frequency of hospitalisations related to suspected and confirmed cases of Covid-19 infection and consequences
Measure: Analysis of the impact of COVID-19 infection on rare skin diseases: complications Time: BaselineDescription: Frequency of hospitalisations related to suspected and confirmed cases of Covid-19 infection and analysis of associated factors: age, gender, pathology, comorbidities, medications
Measure: Analysis of the impact of COVID-19 infection on rare skin diseases: potential comorbidity factors Time: BaselineDescription: Frequency of confirmed and suspected unconfirmed Covid-19 infections; description of clinical signs and signs of an impact on the chronic disease; description of possible therapeutic changes due to the Covid-19 infections
Measure: Analysis of the impact of COVID-19 infection on rare skin diseases: impact on the management of chronic conditions (change in treatment) Time: Baseline